Completed NA INTERVENTIONAL 12-arm NCT03707652

Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)

Three-Day Dosing NAD + Study

Sponsor: Supplement Formulators, Inc.

Conditions Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+)

Interventions Oral Supplement D in combination with oral supplement C Oral supplement A Oral supplement B Oral supplement C Oral supplement D

Updated 4 times since 2018 Last updated: Oct 16, 2018 Started: Mar 12, 2018 Primary completion: May 16, 2018 Completion: May 24, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+) and is currently completed. Supplement Formulators, Inc. leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2018 — Jan 2021 [monthly]

Completed NA

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Supplement Formulators, Inc.

Data source: Supplement Formulators, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Lauderdale, United States